Historical record - last NADAC effective date: 12/20/2023
Product Information
GENTAMICIN 0.3% EYE DROP is a generic product labeled by Pacific Pharma, Inc., priced at $0.9256 per ML under NDC 60758018805. Its NADAC has been published 527 times since Nov 28, 2013.
FDA first approved this application on Oct 10, 1984.
Strength
3 mg/mL
Manufacturer
Pacific Pharma, Inc.NDC
60758018805
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
12/20/2023
Active Ingredients
GENTAMICIN SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA062452FDA Approved
10/10/1984
On Market Since
1/5/1998
Pharmacological Classes
Price Statistics
The NADAC for GENTAMICIN 0.3% EYE DROP has been published 527 times since Nov 28, 2013, and over the history we have for it it has risen 15.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9256 per ML |
|---|---|
| All-time high | $3.5187 (Nov 11, 2015) |
| All-time low | $0.5839 (Nov 17, 2021) |
| Median price | $0.8002 |
| Average price | $1.0135 |
| Largest weekly change | +343.5% (Oct 21, 2015) |
| Weeks tracked | 527 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-18.6%
5Y
+53.6%
All
+15.9%
Last surveyed Dec 27, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the gentamicin sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pacific Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
gentamicin sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoglycoside Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GENTAMICIN 0.3% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for GENTAMICIN 0.3% EYE DROP, manufactured by Pacific Pharma, Inc., is $0.9256 per ML (NDC 60758018805), effective Dec 27, 2023.
How has the price of GENTAMICIN 0.3% EYE DROP changed over time?
Over the history we have for it, the NADAC for GENTAMICIN 0.3% EYE DROP has risen 15.9%. It has been tracked across 527 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GENTAMICIN 0.3% EYE DROP?
Since Nov 28, 2013, the NADAC for GENTAMICIN 0.3% EYE DROP has ranged from a low of $0.5839 (Nov 17, 2021) to a high of $3.5187 (Nov 11, 2015), with a median of $0.8002 per ML.
Are there cheaper alternatives to GENTAMICIN 0.3% EYE DROP?
No other NADAC-published product currently shares the active ingredient and strength of GENTAMICIN 0.3% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GENTAMICIN 0.3% EYE DROP?
GENTAMICIN 0.3% EYE DROP (NDC 60758018805) is labeled by Pacific Pharma, Inc., and CMS classifies it as a generic product.